Procalcitonin for the diagnosis of invasive candidiasis: What is the evidence?

Risultato della ricerca: Article

3 Citazioni (Scopus)

Abstract

Procalcitonin is a widely used marker for the evaluation of infection and sepsis and to guide antibiotic therapy. During the last decade, several studies evaluated its role and diagnostic performance as a surrogate marker for the identification of Candida spp. in suspected invasive candidiasis. A low serum level and a favorable negative predictive value are the main findings for procalcitonin in this setting. The aim of this report is to provide an updated brief summary of the evidence supporting the use of PCT for the management of invasive candidiasis.
Lingua originaleEnglish
pagine (da-a)58-
Numero di pagine2
RivistaJournal of Intensive Care
Volume5
Stato di pubblicazionePublished - 2017

All Science Journal Classification (ASJC) codes

  • Critical Care and Intensive Care Medicine

Fingerprint Entra nei temi di ricerca di 'Procalcitonin for the diagnosis of invasive candidiasis: What is the evidence?'. Insieme formano una fingerprint unica.

Cita questo